Clinical Trial Update: Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 clinical trial evaluating the efficacy of everolimus (RAD001) for autism spectrum disorders and neuropsychological deficits in children with tub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Tuberous Sclerosis Complex

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Tuberous Sclerosis Complex, TSC Related Cognitive Disability | Phase 2, Phase 3 | Status: UNKNOWN